| 1 | your use of the | | | | | | | 2 | 0.45% |
| 2 | sanno ltd uses its | | | | | | | 1 | 0.23% |
| 3 | streamlined our study making | | | | | | | 1 | 0.23% |
| 4 | manage nina skorytchenko ceo | | | | | | | 1 | 0.23% |
| 5 | to manage nina skorytchenko | | | | | | | 1 | 0.23% |
| 6 | easy to manage nina | | | | | | | 1 | 0.23% |
| 7 | and easy to manage | | | | | | | 1 | 0.23% |
| 8 | making it more precise | | | | | | | 1 | 0.23% |
| 9 | study making it more | | | | | | | 1 | 0.23% |
| 10 | our study making it | | | | | | | 1 | 0.23% |
| 11 | that streamlined our study | | | | | | | 1 | 0.23% |
| 12 | skorytchenko ceo avenna sanno | | | | | | | 1 | 0.23% |
| 13 | benefits that streamlined our | | | | | | | 1 | 0.23% |
| 14 | numerous benefits that streamlined | | | | | | | 1 | 0.23% |
| 15 | sanno provided us with | | | | | | | 1 | 0.23% |
| 16 | gamechanger sanno provided us | | | | | | | 1 | 0.23% |
| 17 | a gamechanger sanno provided | | | | | | | 1 | 0.23% |
| 18 | was a gamechanger sanno | | | | | | | 1 | 0.23% |
| 19 | study was a gamechanger | | | | | | | 1 | 0.23% |
| 20 | research study was a | | | | | | | 1 | 0.23% |
| 21 | observational research study was | | | | | | | 1 | 0.23% |
| 22 | nina skorytchenko ceo avenna | | | | | | | 1 | 0.23% |
| 23 | avenna sanno has helped | | | | | | | 1 | 0.23% |
| 24 | ceo avenna sanno has | | | | | | | 1 | 0.23% |
| 25 | they can track a | | | | | | | 1 | 0.23% |
| 26 | with how proactive the | | | | | | | 1 | 0.23% |
| 27 | impressed with how proactive | | | | | | | 1 | 0.23% |
| 28 | very impressed with how | | | | | | | 1 | 0.23% |
| 29 | am very impressed with | | | | | | | 1 | 0.23% |
| 30 | factorsi am very impressed | | | | | | | 1 | 0.23% |
| 31 | lifestyle factorsi am very | | | | | | | 1 | 0.23% |
| 32 | of lifestyle factorsi am | | | | | | | 1 | 0.23% |
| 33 | range of lifestyle factorsi | | | | | | | 1 | 0.23% |
| 34 | where they can track | | | | | | | 1 | 0.23% |
| 35 | customers “using sanno for | | | | | | | 1 | 0.23% |
| 36 | platform where they can | | | | | | | 1 | 0.23% |
| 37 | a platform where they | | | | | | | 1 | 0.23% |
| 38 | offering a platform where | | | | | | | 1 | 0.23% |
| 39 | by offering a platform | | | | | | | 1 | 0.23% |
| 40 | patients by offering a | | | | | | | 1 | 0.23% |